Edition:
India

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

53.28USD
2:29am IST
Change (% chg)

$-1.45 (-2.65%)
Prev Close
$54.73
Open
$54.88
Day's High
$55.45
Day's Low
$52.91
Volume
358,603
Avg. Vol
409,680
52-wk High
$58.67
52-wk Low
$30.02

Biggar, Stephen 

Dr. Stephen R. Biggar M.D. Ph.D. serves as Independent Chairman of the Board of the Company. He has served as a director of our company since January 2013. Dr. Biggar is a Partner at Baker Bros. Advisors LP, a registered investment adviser focused on long-term investments in life-sciences companies. Dr. Biggar joined Baker Bros. Advisors LP in 2000. Dr. Biggar currently also serves on the board of directors of Kiniksa Pharmaceuticals, Ltd. During the past five years, Dr. Biggar served on the board of directors of Synageva BioPharma Corp. Dr. Biggar received an M.D. and a Ph.D. in immunology from Stanford University and received a B.S. in genetics from the University of Rochester.

Basic Compensation

Total Annual Compensation, USD 105,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 214,959
Fiscal Year Total, USD 319,959

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Biggar

319,959

Srdjan Stankovic

5,088,270

Stephen Davis

7,631,250

Elena Ridloff

1,990,870

Austin Kim

1,906,130

Gudarz Davar

--
As Of  31 Dec 2019